Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
3
×
raleigh-durham top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
eli lilly
medicare
national
national top stories
new york blog main
new york top stories
novartis
pfizer
president trump
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
abiraterone
ac immune
acorda therapeutics
adalimumab
administration
What
drug
3
×
pharmaceutical
3
×
prices
acute
addresses
alzheimer’s
approval
away
bio
bringing
causes
ceos
companies
condition
dc
decades
different
eli
executives
fail
fda
friday
gathered
gene
giant
giving
groups
hearing
held
increases
lasmiditan
latest
lilly
lilly’s
lower
medication
migraine
new
oks
pharma
Language
unset
Current search:
drug
×
" raleigh-durham blog main "
×
pharmaceutical
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
